Effects of inhaled salbutamol in primary pulmonary hypertension
Authors:
- E. SpiekerkoetterESE. Spiekerkoetter
- H. FabelHFH. Fabel
- M.M. HoeperMHM.M. Hoeper
Open Access
- 1 September 2002
- journal article
- clinical trial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 20 (3) , 524-528
Abstract
Although lung function is grossly normal in patients with primary pulmonary hypertension (PPH), mild-to-moderate peripheral airflow obstruction can be found in the majority of patients with this disease. Therefore, β2-agonists may affect pulmonary function, blood gases and haemodynamics in patients with PPH.Pulmonary function testing, blood gas measurements and right heart catheterisation was performed in 22 patients with PPH and the acute effects of inhaled salbutamol (0.2 mg) were measured.Salbutamol caused an increase in the forced expiratory volume in one second (FEV1) from 2446±704 to 2550±776 mL. The mean expiratory flow at 50% of the vital capacity (MEF50) rose from 58±17 to 66±21% pred. The pulmonary artery pressures remained unchanged after inhalation of salbutamol, but the cardiac output increased significantly from 3.9±1.4 to 4.2±1.4 L·min−1accompanied by significant increases in stroke volume and mixed venous oxygen saturation as well as a significant decrease in pulmonary vascular resistance. The arterial oxygen tension rose from 9±2.4 kPa (68±18 mmHg) at baseline to 9.7±2.8 kPa (73±21 mmHg) after inhalation of salbutamol, the alveolo-arterial oxygen gradient values improved from 6±2.5 kPa (45±19 mmHg) to 5.1±2.9 kPa (38±22 mmHg), respectively.Inhaled salbutamol has beneficial acute effects on pulmonary function, blood gases and haemodynamics in patients with primary pulmonary hypertension.Keywords
This publication has 29 references indexed in Scilit:
- Peripheral airway obstruction in primary pulmonary hypertensionThorax, 2002
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β familyJournal of Medical Genetics, 2000
- Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II GeneThe American Journal of Human Genetics, 2000
- Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin AnalogueNew England Journal of Medicine, 2000
- Airway Responsiveness to Inhaled Albuterol in Patients wit Pulmonary HypertensionClinical Pediatrics, 1999
- Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.Journal of Clinical Investigation, 1997
- Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromideThe American Journal of Cardiology, 1994
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failureEuropean Heart Journal, 1993
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionNew England Journal of Medicine, 1992